Menu
Search
|

Menu

Close
X

AquaBounty Technologies Inc AQB.OQ (NASDAQ Stock Exchange Capital Market)

2.65 USD
-- (--)
As of Feb 16
chart
Previous Close 2.65
Open --
Volume --
3m Avg Volume 18,135
Today’s High --
Today’s Low --
52 Week High 18.25
52 Week Low 2.26
Shares Outstanding (mil) 12.59
Market Capitalization (mil) 33.36
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, USD)
FY17
0
FY16
0
FY15
0
EPS (USD)
FY17
-0.755
FY16
-2.035
FY15
-1.399
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
34.43
Price to Sales (TTM)
vs sector
626.06
8.57
Price to Book (MRQ)
vs sector
1.15
5.14
Price to Cash Flow (TTM)
vs sector
--
25.75
Total Debt to Equity (MRQ)
vs sector
15.14
15.12
LT Debt to Equity (MRQ)
vs sector
14.87
11.85
Return on Investment (TTM)
vs sector
--
13.54
Return on Equity (TTM)
vs sector
--
14.80

EXECUTIVE LEADERSHIP

Richard Clothier
Non-Executive Independent Chairman of the Board, Since 2006
Salary: --
Bonus: --
Ronald Stotish
President, Chief Executive Officer, Executive Director, Since 2008
Salary: $350,659.00
Bonus: $116,424.00
David Frank
Chief Financial Officer, Treasurer, Since 2015
Salary: $263,172.00
Bonus: $66,250.00
Christopher Martin
General Counsel, Corporate Secretary, Since 2015
Salary: --
Bonus: --
Alejandro Rojas
Chief Operating Officer - AquaBounty Farms division, Since 2014
Salary: $215,000.00
Bonus: $5,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

2 Clock Tower Pl Ste 395
MAYNARD   MA   01754-2539

Phone: +1978.6486000

AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company's subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company's technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc., and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company's AquAdvantage Salmon.

SPONSORED STORIES